Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Julphar
UBS
Boehringer Ingelheim
Cantor Fitzgerald

Generated: March 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for SF1126

« Back to Dashboard

US Patents for SF1126

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SF1126 ➤ Try a Free Trial Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity The University of North Carolina at Chapel Hill (Chapel Hill, NC) ➤ Try a Free Trial
SF1126 ➤ Try a Free Trial Therapeutic uses of selected pyrazolopyrimidine compounds with anti-Mer tyrosine kinase activity The University of North Carolina at Chapel Hill (Chapel Hill, NC) ➤ Try a Free Trial
SF1126 ➤ Try a Free Trial Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity The University of North Carolina at Chapel Hill (Chapel Hill, NC) ➤ Try a Free Trial
SF1126 ➤ Try a Free Trial MerTK-specific pyrazolopyrimidine compounds The University of North Carolina at Chapel Hill (Chapel Hill, NC) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for SF1126

Drugname Country Document Number Estimated Expiration Related US Patent
SF1126 Australia 2015244171 2034-04-11 ➤ Try a Free Trial
SF1126 Australia 2015244179 2034-04-11 ➤ Try a Free Trial
SF1126 Canada 2945128 2034-04-11 ➤ Try a Free Trial
SF1126 Canada 2945129 2034-04-11 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
Express Scripts
McKinsey
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.